LinkedIn




Hot Topics


NYC Health: Bicillin-LA (benzathine penicillin G) shortage (5-4-2016)

Posted May 4, 2016

2016 DOHMH ADVISORY # 9: Bicillin-LA (benzathine penicillin G) shortage

  • Shortages of Bicillin-LA (benzathine penicillin G) reported nationally and expected to resolve by July 2016.
  • Providers should prioritize treatment of pregnant women infected or exposed to syphilis.

Long-acting benzathine penicillin G is the standard treatment for patients infected with syphilis and the only treatment for syphilis-infected pregnant women. Due to the limited availability of this medication, we advise providers to prioritize treatment of pregnant women infected or exposed to syphilis. Additional information on this drug shortage can be found on the CDC’s website at http://www.cdc.gov/std/treatment/drugnotices/bicillinshortage.htm and on the FDA’s website at
http://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Penicillin%20G%20Benzathine%20%28Bicillin%20L-A%29%20Injection&st=c&tab=tabs-1.

Providers should continue to report all drug shortages. Information on reporting drug shortages is available at http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm142398.htm.

To download and view a PDF of the advisory, please click here.

 

^ Return to Top


Hepatitis C Kills More Americans than Any Other Infectious Disease (5-4-2016)

Posted May 4, 2016

New CDC studies underscore urgency of hepatitis C testing and treatment, especially for baby boomers

 

^ Return to Top


FDA Publishes Revised Draft Guidance for Developing Direct-Acting Antiviral Drugs for Treatment of Chronic Hep C (5-3-2016)

Posted May 3, 2016

FDA has revised a draft guidance, titled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment.

The purpose of the guidance is to assist sponsors in the clinical development of direct-acting antiviral (DAA) drugs for the treatment of chronic hepatitis C (CHC) from the pre-investigational new drug application (pre-IND) through the new drug application (NDA) and postmarketing stages.

FDA defines direct-acting hepatitis C virus (HCV) antivirals as drugs that interfere with specific steps in the HCV replication cycle through a direct interaction with the HCV genome, polyprotein,or its polyprotein cleavage products.

The guidance addresses the FDA’s current thinking regarding the overall development program and clinical trial designs to support DAA drugs.

The guidance is available on the FDA website.

To read the complete FDA update, please visit https://content.govdelivery.com/accounts/USFDA/bulletins/14713db

 

^ Return to Top


HIV Quality of Care Clinical Advisory Committee Meeting Minutes and Presentations (5-3-2016)

Posted May 3, 2016

The March New York State Department of Health AIDS Institute’s HIV Quality of Care Clinical Advisory Committee meeting minutes and presentations are available by clicking here.

 

^ Return to Top


NYS Clinical Education: New CE Courses, Conference, STD Lunch and Learn & CEI Line (5-3-2016)

Posted May 3, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • Last chance to register! New York State 2016 Clinical Conference on HIV and Hepatitis C: Advancing Care through Knowledge, Policy, and Implementation
  • STD Lunch and Learn Series: Congenital Syphilis
  • CEI Line

 

^ Return to Top


FDA Launches Public Education Campaign to Prevent and Reduce Tobacco Use Among LGBT Young Adults (5-2-2016)

Posted May 2, 2016

The U.S. Food and Drug Administration today announced the launch of a historic public education campaign aimed at preventing and reducing tobacco use among lesbian, gay, bisexual and transgender (LGBT) young adults ages 18-24. Of the more than 2 million LGBT young adults in the U.S., more than 800,000 smoke occasionally. The “This Free Life” campaign is designed to specifically reach the occasional or “social” smokers in the LGBT community to help prevent tobacco-related disease and the loss of tens of thousands LGBT lives to tobacco use each year. [READ MORE]

 

^ Return to Top


New PrEP Brochures from CDC: Paying for and Adherence to (5-2-2016)

Posted May 2, 2016

The following new resources are now available from the CDC.

Fact Sheets and Brochures

For more information on PrEP, please visit the CDC website at http://www.cdc.gov/hiv/risk/prep/index.html

 

^ Return to Top


CDC’s New Risk Reduction Tool: Exploring Prevention Options (5-2-2016)

Posted May 2, 2016

In December 2015, at the National HIV Prevention Conference in Atlanta, CDC launched a pilot version of a new tool that provides updated information about the many prevention methods now available. It’s called the HIV Risk Reduction Tool (HRRT). I would like to tell you how we arrived at the new messages contained in the tool and to invite you to help us continue to improve it. [READ MORE]

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (5-2-2016)

Posted May 2, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Updated AETC Program Design Files and Templates
  • Department of Health and Human Services Implementation Guidance to Support Certain Components of Syringe Services Programs, 2016
  • Health, United States, 2015
  • Retooling Your HIV/AIDS Organization to Compete in the Ever Evolving Healthcare Landscape (webinar) – May 10, 2016, 2:00 – 3:00 PM ET
  • Going Viral: HIV, HCV and Worker Safety in 2016 – June 16, 2016, 8:30 AM – 3:30 PM ET, Westborough, MA
  • Awareness Days

 

^ Return to Top


Shortage of Bicillin-LA (benzathine penicillin G) (4-29-2016)

Posted April 29, 2016

CDC was recently notified of difficulties in obtaining Bicillin-LA (benzathine penicillin G). Benzathine penicillin G is the recommended treatment for syphilis and the only treatment option for pregnant women infected with or exposed to syphilis. The recommended treatments for syphilis are outlined in 2015 STD Treatment Guidelines along with alternative regimens.

For more information on the shortage, see Bicillin-LA (benzathine penicillin G) Shortage.

 

^ Return to Top


May Is Hepatitis Awareness Month (4-29-2016)

Posted April 29, 2016

Each May, many partners across the federal government, including the Department of Health and Human Services (HHS) and its agencies, join with numerous non-federal and community allies to raise awareness of viral hepatitis during Hepatitis Awareness Month. The month-long observance includes national Hepatitis Testing Day on May 19th. [READ MORE]

 

^ Return to Top


WHO Issues Updated HCV Guidelines for Treatment (4-29-2016)

Posted April 29, 2016

Due to the rapid development and evolution of direct-acting viral treatments, WHO issued updated guidelines for the screening, care and treatment of individuals with chronic hepatitis C virus infection at the International Liver Congress [READ MORE].

 

^ Return to Top


NYC Health: Updated Diagnostic Testing for Zika Virus and Interpretation of Results (4-28-2016)

Posted April 28, 2016

2016 DOHMH Advisory #5 (UPDATED): Diagnostic Testing for Zika Virus and Interpretation of Results

  • As of April 28, 2016, the Public Health Laboratory will no longer routinely test specimens submitted for Zika testing from symptomatic patients for dengue and chikungunya viruses by reverse transcriptase polymerase chain reaction (RT-PCR). Clinicians should request RT-PCR testing for dengue and chikungunya viruses through a commercial laboratory.
  • Diagnosis of Zika virus infection often includes testing by both RT-PCR and serology.
  • Some patients will require a follow-up (convalescent) specimen for serologic testing to verify Zika virus infection or determine which flavivirus caused the infection.
  • Call the PAL to arrange all Zika virus testing at 1-866-692-3641.

To read the NYC DOHMH Dear Colleague Letter, please click here.

NYS Zika Virus Information Line: 1-888-364-4723

 

^ Return to Top


NYS Medicaid Update: April (4-27-2016)

Posted April 27, 2016

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the April 2016 Medicaid Update.

Please click the link below to download the current edition.

http://www.health.ny.gov/health_care/medicaid/program/update/2016/april_16mu.pdf (PDF)

To see a list of all of the DOH Medicaid Updates, please visit http://www.health.ny.gov/health_care/medicaid/program/update/2016/

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (4-26-2016)

Posted April 26, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


CDC: HIV Infection & Zika Virus (4-26-2016)

Posted April 26, 2016

To view the article, please visit http://www.cdc.gov/zika/hc-providers/hiv-zika.html

 

^ Return to Top


New CDC Fact Sheet: HIV Among Youth (4-26-2016)

Posted April 26, 2016

  • Youth aged 13 to 24 accounted for more than 1 in 5 new HIV diagnoses in 2014.
  • Young gay and bisexual males accounted for 8 in 10 HIV diagnoses among youth in 2014.
  • At the end of 2012, 44% of youth ages 18 to 24 years living with HIV did not know they had HIV.

For more information, please visit http://www.cdc.gov/hiv/group/age/youth/

 

^ Return to Top


AIDSinfo: At-a-Glance (4-22-2016)

Posted April 22, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

  • AIDSinfo Education Materials Now Include Infographics
  • AIDSinfo Releases New Consumer Fact Sheets
  • CDC Updates Nonoccupational Postexposure Prophylaxis (nPEP) Guidelines
  • National Library of Medicine Announces Solicitation of Quotations for the 2016 HIV/AIDS Community Information Outreach Projects
  • Recent HIV/AIDS News

 

^ Return to Top


NYC Health: Increase in Drug Overdoses Deaths and Increased Presence of Fentanyl in NYC (4-21-2016)

Posted April 21, 2016

Increase in drug overdoses deaths and increased presence of fentanyl in New York City

 

^ Return to Top


STD Awareness Month: CDC Encourages Everyone to Talk, Test, and Treat (4-20-2016)

Posted April 20, 2016

A special note to the public from Dr. Gail Bolan, Director, Division of STD Prevention, CDC, this STD Awareness Month. April is STD Awareness Month, which gives us the opportunity to talk about sexual health in an inclusive way that speaks to individuals from all walks of life. Sex is a part of most of our lives—but sexually transmitted diseases (STDs) do not have to be one of the “facts of life.” [READ MORE]

 

^ Return to Top


HIV Training NY: Peer Certification Tests Scheduled, Study Guides Available Soon (4-19-2016)

Posted April 19, 2016

New Developments in AI Peer Certification Program  

The New York State Department of Health AIDS Institute (AI) is pleased to announce several important developments in the AI’s Peer Worker Certification effort. To become certified, Peer Workers must:

  • Complete foundational/readiness training or submit a personal statement;
  • Complete 90 hours of Peer Worker training from the Peer Worker Course   Catalogue;
  • Have a satisfactory supervisor’s evaluation on a 500-hour practicum;
  • Agree to follow the AI Peer Worker code of ethics; and
  • Pass a knowledge exam.

The three updates below pertain to the Peer Worker knowledge exam and to the Supervisor Practicum Evaluation Form.

 

Peer Certification Exam Study Guides Now Available

The AI has developed Study Guides to help individuals prepare for the Peer Worker certification knowledge exam. The Study Guides are designed for each of the different certification tracks – HIV, HCV, and Harm Reduction. They are available
here on our websit: https://www.hivtrainingny.org/Home/PeerCertification and
via the links below:

Study Guide for Certified HIV Peer Worker Online Exam

Study Guide for Certified HCV Peer Worker Online Exam

Study Guide for Certified HR Peer Worker Online Exam

These study guides are optional resources, but provide a comprehensive summary of all the knowledge and skills that AI Certified Peer Workers should have. We expect that applicants who use the study guides will have all the information necessary to successfully complete the exam.

 

Peer Certification Knowledge Exams to Be Available On-Line Starting May 2, 2016

Peer Workers who have started an on-line application for AI certification will be able to take the knowledge exam through their on-line application beginning May 1, 2016. When you open the application, you will find a tab on the right side of the screen labeled “Exam.” You can take the exam whenever you are ready after May 1. Although you may take the exam at any time, we recommend you complete most or all of the 90 hours of required training before taking the exam.

 

Peer Worker Supervisor Practicum Evaluation Form to Be Available On-Line Beginning May 2, 2016

As described above, all certified Peer Workers must complete a 500-hour supervised practicum with their sponsor agency to gain real life peer work experience and have an opportunity to practice their skills — and to see if peer work is really for them. In conjunction with the online exam launch, the Supervisor Practicum Evaluation Form will be available for supervisors of peer workers who seek certification. Supervisors can complete the form and review it with their peers before the peers upload the evaluation into their online certification. The Supervisor Practicum Evaluation Form is intended to convey information about a peer worker’s ability to provide peer services and to apply Core Competencies in a workplace setting.

The AI Peer Certification team has been working with peer workers to meet their needs and assist them throughout the certification process. We encourage anyone interested in peer certification to review the important resources at: https://www.hivtrainingny.org/Home/PeerCertification, including:

Peer Certification FAQ

Peer Certification Course Catalog

Peer Certification Code of Ethics

Course Tracker Forms

Core Competencies

 

Additional Questions? Call 518-474-3045 or e-mail Cassandra Kahl at cassandra.kahl@health.ny.gov

 

^ Return to Top


NYS Clinical Education: New CE Courses & Learning Modules, Webinar, Treatment for Hepatitis C, PrEP Payment Options (4-19-2016)

Posted April 19, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

 

^ Return to Top


CDC Releases Updated nPEP Guidelines (4-18-2016)

Posted April 18, 2016

The Centers for Disease Control and Prevention (CDC) released Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV, which updates and expands the 2005 U.S. Department of Health and Human Services recommendations for medical practitioners regarding nonoccupational postexposure prophylaxis (nPEP) use for persons in the United States. Updated Occupational PEP Guidelines, which address case management for persons with possible HIV exposure in health care settings, were published separately in 2013. Awareness of nPEP and its availability for both clinical providers and those who are eligible to receive it are critical to ensure that nPEP reaches those who need it most urgently.

For more information, please visit http://stacks.cdc.gov/view/cdc/38856

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (4-18-2016)

Posted April 18, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


Update to Recommendations for Testing, Managing, and Treating Hepatitis C (4-15-2016)

Posted April 15, 2016

AASLD and the Infectious Diseases Society of America (IDSA), in collaboration with the International Antiviral Society-USA (IAS-USA) just released a new section on www.hcvguidelines.org.

 

^ Return to Top


FDA HIV Updates: Approval of Descovy (emtricitabine (FTC) and tenofovir alafenamide (TAF) fixed-dose combination) (4-15-2016)

Posted April 15, 2016

On April 4, 2016 FDA approved DESCOVY, a two-drug fixed dose combination tablet containing 2 HIV nucleoside analog reverse transcriptase inhibitors (NRTIs), emtricitabine (FTC) and tenofovir alafenamide (TAF). Each DESCOVY tablet contains 200 mg of FTC and 25 mg of TAF (equivalent to 28 mg of tenofovir alafenamide fumarate).

DESCOVY is not a complete regimen for the treatment of HIV-1 infection and must be combined with other antiretroviral agents to form a complete regimen.

To read the complete FDA bulletin, please visit https://content.govdelivery.com/accounts/USFDA/bulletins/1413eda

 

^ Return to Top


AETC ShareSpot: New HIV Meds Update (4-15-2016)

Posted April 15, 2016

Visit ShareSpot to read the latest HIV Meds Update, Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy,” by Jennifer Cocohoba, PharmD, University of California, San Francisco, Center for HIV Information. This update is a brief summary of three studies presented at 2016 CROI that support the use of efavirenz, dolutegravir, and darunavir during pregnancy.

HIV Meds Updates are written by Susa Coffey, MD, Co-Investigator & Medical Editor at the AETC National Coordinating Resource Center, and pharmaceutical experts at the University of California, San Francisco, Center for HIV Information. Updates are posted to ShareSpot as new information about HIV medications becomes available.

 

^ Return to Top


Innovative New Programme Set to Treat 10,000 Patients Co-Infected with Hepatitis C and HIV (4-14-2016)

Posted April 14, 2016

The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

Read the full announcement from CHAI and AmeriCares here.

 

^ Return to Top


Report Concludes Elimination of Hepatitis B & C in U.S. Feasible (4-12-2016)

Posted April 12, 2016

Yesterday the National Academies of Sciences, Engineering and Medicine released Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report , which affirms that it would be possible to eliminate hepatitis in the U.S. with the right resources, commitment, and strategy. [READ MORE]

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (4-11-2016)

Posted April 11, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


April 18: Inaugural National Transgender HIV Testing Day (NTHTD) (4-11-2016)

Posted April 11, 2016

Transgender communities in the United States are among the groups at highest risk for HIV infection. Many of us in the transgender (trans) community have been dismayed by the continued impact of HIV and AIDS on our trans sisters and brothers. We have worked hard to address the epidemic from within—with the limited resources we’ve… [READ MORE]

 

^ Return to Top


Eliminating the Public Health Problem of Hepatitis B and C in the United States (4-11-2016)

Posted April 11, 2016

The National Academy of Medicine (formerly the Institutes of Medicine) Phase I report Eliminating the Public Health Problem of Hepatitis B and C in the United States was released today, April 11, 2016. The report explores the barriers that must be overcome to eliminate hepatitis B and hepatitis C in the United States – and reaffirms that hepatitis elimination can be achieved with the right resources, commitment, and strategy.

Messages from the report include:

  • Eliminating (meaning complete termination of any incident infections in a population) hepatitis B and C in the United States is feasible, but it will take considerable will and resources.
  • Universal vaccination could eradicate hepatitis B, but it would take two generations. In the meantime, there is no cure for the millions already infected.
  • There is a need to better understand the virus and the management of chronic hepatitis B infection. There is a need for more physicians trained in the management of chronic hepatitis B infection.
  • Reaching elimination targets for hepatitis C mortality is highly feasible given the long latency of infection, the curative treatments, and the decreased number of infected persons younger than the Birth Cohort (persons born during 1945-1965).

The full report is available at www.nas.edu/HepatitisElimination.

The Centers for Disease Control and Prevention co-sponsored the report, which examines scientific and policy issues related to hepatitis B and C. The follow-up Phase 2 report is expected to include specific recommendations and targets for elimination.

 

^ Return to Top


AIDSinfo: At-a-Glance (4-8-2016)

Posted April 8, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

  • FDA Approves Descovy (a Fixed-Dose Combination Tablet) to Treat HIV Infection
  • AIDSinfo Updates Consumer Fact Sheets on HIV Treatment
  • FDA Updates Truvada Labeling
  • April 10 is National Youth HIV/AIDS Awareness Day
  • NIH Launches Large Clinical Trials of Antibody-Based HIV Prevention

 

^ Return to Top


Saving Lives and Improving Health Care through Innovation in Organ Donations and Transplants (4-7-2016)

Posted April 7, 2016

There are currently more than 120,000 people on the waiting list for an organ in the United States. Twenty-two people a day die waiting. But today, we’re taking one step forward to change that. In honor of National Donate Life Month, the President issued a Proclamation that solidifies his Administration’s commitment to shortening the organ waiting list. [READ MORE]

 

^ Return to Top


The White House – Presidential Proclamation: National Public Health Week, 2016 (4-5-2016)

Posted April 5, 2016

During National Public Health Week, we join together to enhance public health — the foundation of our security and well-being — here at home and around the world. By supporting health professionals and embracing our obligations to promote public health and protect our planet, we can uphold our shared responsibility to preserve the promise of a happy and healthy life for our children and grandchildren. [READ MORE]

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (4-4-2016)

Posted April 4, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


Federal Work Group Looks to Future of Viral Hepatitis Action Plan (4-4-2016)

Posted April 4, 2016

Viral hepatitis is a growing public health problem in the United States. This increase is being fueled in part by the widespread epidemic of opioid abuse that is devastating families and communities across the country. These new cases add to the millions of people who are already living with viral hepatitis, many of whom have never injected drugs. There is an urgent need for us to strengthen our response to the threat that viral hepatitis poses to the health of our nation. We are currently in the third and final year of the national Viral Hepatitis Action Plan,, and leaders across the Federal government have begun the important work of building a new plan that will establish goals and priorities and guide the nation’s efforts through 2020. [READ MORE]

 

^ Return to Top


Quick News Update from OMD AIDS Institute (4-4-2016)

Posted April 4, 2016

OMD SCREENSHOT – April 1st, 2016

  • Don’t Miss Out on the ACTHIV Conference! There are only a few more weeks left to register for this unique conference for frontline clinicians and primary care physicians. It will be held in Dallas, Texas from April 28 to April 30, 2016.

 

^ Return to Top


NQC e-Newsletter: NQC Extends Quality Award Deadline (4-1-2016)

Posted April 1, 2016

Please click here to view the e-Newsletter from the National Quality Center (NQC).

 

^ Return to Top


Quick News Update from OMD AIDS Institute (3-31-2016)

Posted March 31, 2016

OMD SCREENSHOT – March 31st, 2016

 

^ Return to Top


FDA HIV Updates: Truvada (emtricitabine/tenofovir disoproxil fumarate) Pediatric Labeling Expanded (3-31-2016)

Posted March 31, 2016

The Truvada (emtricitabine/tenofovir disoproxil fumarate) tablet label was recently updated to expand the indication to include pediatric patients weighing at least 17 kilograms and the addition of the following strength tablets (100/150 mg, 133/200 mg and 167/250 mg).

The updates to the label are summarized here.

 

^ Return to Top


Syringe Service Programs: New HHS Guidance and Resources (3-29-2016)

Posted March 29, 2016

HHS has released new Syringe Services Programs (SSPs) guidance for HHS-funded programs. SSPs have been demonstrated to be an effective component of a comprehensive approach to prevent HIV and viral hepatitis among people who inject drugs.

Read the new Guidance for Syringe Services Programs [PDF - 960 KB]

The U.S. is experiencing a growing opioid epidemic, which has made many communities vulnerable to outbreaks of HIV and viral hepatitis among people who inject drugs (PWID). To address this issue, Members of Congress worked together late last year on a broad, bipartisan basis to revise a longstanding ban on the use of federal funds for Syringe Services Programs (SSPs). [READ MORE]

 

^ Return to Top


NYS Clinical Education: New CE Courses, Clinical Update, Webinar & Conference (3-29-2016)

Posted March 29, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (3-28-2016)

Posted March 28, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


AIDSinfo: National Library of Medicine Announces Solicitation of Quotations for the 2016 HIV/AIDS Community Information Outreach Projects (3-25-2016)

Posted March 25, 2016

To read about the National Library of Medicine Solicitation of Quotations and other updates, please view the AIDSinfo At-a-Glance e-news issue at https://aidsinfo.nih.gov/e-news/archive/2016/3/25

 

^ Return to Top


HIV Training NY: Support Your Peer Workers with Supervisory Training (3-24-2016)

Posted March 24, 2016

AIDS Institute Offers Peer Worker Supervisor and Program Director Trainings and Resources

Recognizing the unique role that peers can and have played in improving health outcomes, the New York State Department of Health AIDS Institute (AI) has created a program to certify peer workers who are living with HIV, hepatitis C, and/or have a history of accessing harm reduction services.

It is critical for supervisors to also receive education and training to support peers who are providing services as part of a care team. Peers report feeling more supported when their supervisors attend the trainings offered as part of this initiative. In offering these optional trainings, our goal is to provide comprehensive resources for peer workers, peer supervisors and peer programs to be as successful as possible.

The following is a compilation of training and resources offered by the AI Education and Training Programs for peer supervisors to enhance their skills, knowledge and capacity to support a peer program.

Supervisor Training for Implementing Peer-Delivered Services Now Offered Upstate and in NYC

This two-day, in-person supervisor training will prepare direct supervisors of peer workers to establish effective supervisory relationships with the peer workers they supervise. Supervisors play an important roles in the successful roll-out and implementation of peer-delivered services for people with HIV, HCV and behavioral health issues. This session will review emerging best practices in hiring, retaining and supervising peer workers. It will focus on communication skills, team-building, integrating new peer workers into the organizational structure and supporting peer workers in their efforts to establish and maintain professional boundaries between themselves and their clients.

Objectives:

By the end of the training, supervisors of peer workers will be able to:

  • Review best practices for integrating peer workers into the overall organizational structure and culture.
  • Recall AI Peer Worker core competencies and identify the unique role peer workers play on the care team.
  • Define job descriptions and responsibilities for peer workers.
  • Recall the AI Peer Worker Code of Ethics and support peer workers in adhering to all items in the Code of Ethics.
  • Explore possible challenges and concerns regarding supervision of peer workers.
  • Identify important components of the supervision for peer workers, especially during the pre-certification practicum period.
  • Identify and practice communication skills essential for effective supervision.
  • Examine the importance of professional boundaries for peer workers and how to support peer workers in developing and maintaining professional boundaries.
  • Explore other important components of hiring, retaining and supervising peer workers, including cultural competency, conflict resolution, team-building and action planning.

Scheduled Trainings

Location: NYSDOH Central New York Regional Office, Conference Room 4A/4B, 217 S. Salina Street Syracuse, NY 13202.
Date: Thursday-Friday, May 12-13, 2016
Time: 9 am-5 pm
To register: https://hivtrainingny.org/Account/LogOn?crs=1883

Location: Alliance for Positive Health, 927 Broadway, Albany, NY 12207
Date: Monday-Tuesday, June 6-7, 2016
Time: 9 am-5 pm
To register: https://hivtrainingny.org/Account/LogOn?crs=1882

Location: Cicatelli Associates/NYC, 19th floor training room, 505 Eighth Avenue, New York, NY 10018
Date: Tuesday-Wednesday, June 28-29, 2016
Time: 9 am- 5pm
To register: https://hivtrainingny.org/Account/LogOn?crs=1825

Archived Webinar: AIDS Institute Peer Worker Certification – Process, Requirements and Starting Your Application

This 90-minute webinar reviews the requirements for AI Certification of Peer Workers and provides a step-by step review of the process for submitting an application for certification.
To access the webinar go to: https://hivtrainingny.org/Account/LogOn?crs=1805

Integrating Certified Peer Workers into Health Care Service Delivery for Program Directors and Supervisors

This 90-minute webinar reviews the important role that program directors and supervisors should play in developing and implementing peer-delivered services with a focus on policies and procedures for hiring and supervising peer workers. Topics to be reviewed include: integrating peers into multidisciplinary teams; best practices for supervising and coaching peer workers; and strategies to support the development of peer worker skills and competencies. This live webinar is scheduled for:

April 25, 2016, 2 pm-3:30 pm: https://hivtrainingny.org/Account/LogOn?crs=1775

July 24, 2016, 10 am-11:30 am: https://hivtrainingny.org/Account/LogOn?crs=1705

Archived Webinar

To access: https://hivtrainingny.org/Account/LogOn?crs=1826

Additional Resources

Peer Certification FAQhttps://www.hivtrainingny.org/FAQDocs/PeerCertificationFAQ.pdf

Organization Readiness Assessment for Implementing Peer-Delivered Services: https://www.hivtrainingny.org/FAQDocs/ORGANIZATIONALASSESSMENT11315.pdf

Training and Education Initiative Peer Certification Webpage, Application and Additional Resources https://www.hivtrainingny.org/Home/PeerCertification

Questions? Please call 518-474-3045 or email hivet@health.ny.gov

To register for any course, click on the appropriate registration link and enter your account log-in information.If you do not have an account with hivtrainingny.org, you will need to sign up for one prior to registering for a course. For help in registering, please contact the NYSDOH AIDS Institute’s HIV Education and Training Program at (518) 474-3045.

 

^ Return to Top


Slides and Audio from AVAC Webinar: Long-Acting Injectable Antiretrovirals for HIV Treatment and Prevention (3-24-2016)

Posted March 24, 2016

To view slides and audio from AVAC webinar on Long-Acting Injectable Antiretrovirals for Treatment and Prevention, please visit http://www.avac.org/post-croi-2016-webinar-series

 

^ Return to Top


FDA Takes Important Step to Increase the Development of, and Access to, Abuse-Deterrent Opioids (3-24-2016)

Posted March 24, 2016

To view the FDA News Release, please visit http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm492237.htm

 

^ Return to Top


Farewell Letter from the White House Director of the Office of National AIDS Policy (3-24-2016)

Posted March 24, 2016

After two extraordinary years with the Obama Administration, today is my last as the Director of the Office of National AIDS Policy. It’s been the opportunity of a lifetime to serve President Obama, a man I admire so deeply, and the American people, helping to lead our efforts to improve HIV research, prevention and care. [READ MORE]

To view the letter from Douglas Brooks, please visit https://www.whitehouse.gov/blog/2016/03/24/hail-and-farewell.

 

^ Return to Top


Dear NYC and NYS PrEP Providers Letter (3-23-2016)

Posted March 23, 2016

New York City and New York State Health Departments continue to fully support the use of TDF/FTC as PrEP for individuals at risk of HIV infection. The rare event reported at 2016 CROI provides an opportunity to revisit clinical guidelines for PrEP, and to clarify the importance of communicating with patients about PrEP and the risk of HIV and other sexually transmitted infections (STIs). For more information, please click here.

 

^ Return to Top


NYS Medicaid Update: March (3-23-2016)

Posted March 23, 2016

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the March 2016 Medicaid Update.

Please click the link below to download the current edition.

http://www.health.ny.gov/health_care/medicaid/program/update/2016/mar16_mu.pdf (PDF)

To see a list of all of the DOH Medicaid Updates, please visit http://www.health.ny.gov/health_care/medicaid/program/update/main.htm

 

^ Return to Top


SAMHSA Announces Availability of $33M to Integrate HIV Services into Substance Abuse Disorder Treatment Programs for Women (3-22-2016)

Posted March 22, 2016

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment, is accepting applications for fiscal year (FY) 2016 Targeted Capacity Expansion HIV: Substance Use Disorder Treatment for Racial/Ethnic Minority Women at High-Risk for HIV/AIDS (TCE-HIV: Minority Women) grants. [READ MORE]

 

^ Return to Top


AETC ShareSpot: Three New HIV Meds Updates Added (3-22-2016)

Posted March 22, 2016

Please visit ShareSpot to read the latest HIV Meds Updates

HIV Meds Updates are written by Susa Coffey, MD, Co-Investigator & Medical Editor at the AETC National Coordinating Resource Center, and pharmaceutical experts at the University of California, San Francisco, Center for HIV Information. Updates are posted to ShareSpot as new information about HIV medications becomes available. More Updates are coming soon.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (3-21-2016)

Posted March 21, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


HIVandHepatitis.com: Full Listing of CROI 2016 Coverage (3-18-2016)

Posted March 18, 2016

To view the HIVandHepatitis.com full listing of CROI 2016 coverage, please visit http://207.56.172.200/hivandhepatitis/croi2016.html

 

^ Return to Top


NYC Health: New Process for Ordering Zika Virus Testing (3-18-2016)

Posted March 18, 2016

2016 DOHMH Alert #7: New Process for Ordering Zika Virus Testing

  • Healthcare providers must now call the NYC Health Department for approval before testing New York City residents for Zika virus infection.
  • Call 1-866-692-3641 from Monday–Friday, 9am–5pm, to obtain approval.

To read the NYC DOHMH Dear Colleague Letter, please click here.

NYS Zika Virus Information Line: 1-888-364-4723

 

^ Return to Top


CROI 2016 Plenary Session on HIV in Transgender Populations (Video) (3-18-2016)

Posted March 18, 2016

The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston last month featured a first-ever plenary session on HIV in transgender populations by Dr. Tonia C. Poteat. [READ MORE AND WATCH HIGHLIGHTS]

 

^ Return to Top


NYC Health: Diagnostic Testing for Zika Virus and Interpretation of Results (3-17-2016)

Posted March 17, 2016

2016 DOHMH Advisory #5: Diagnostic Testing for Zika Virus and Interpretation of Results

Please share with your colleagues in Obstetrics/Gynecology, Maternal/Fetal Medicine, Internal Medicine, Family Medicine, Emergency Medicine, Urgent Care, Pediatrics, Neonatology, Infectious Disease, and Neurology:

  • Diagnosis of Zika virus infection requires reverse transcriptase polymerase chain reaction testing (RT-PCR) and serologic testing.
  • Many patients will require a follow-up (“convalescent”) specimen for serologic testing to verify Zika virus infection or determine which flavivirus caused the infection.

To read the NYC DOHMH Dear Colleague Letter, please click here.

NYS Zika Virus Information Line: 1-888-364-4723

 

^ Return to Top


HHS Awards $94 Million to Health Centers to Help Treat the Prescription Opioid Abuse and Heroin Epidemic in America (3-17-2016)

Posted March 17, 2016

The Health and Human Services (HHS) Secretary Sylvia M. Burwell announced $94 million in Affordable Care Act funding to 271 health centers in 45 states, the District of Columbia, and Puerto Rico to improve and expand the delivery of substance abuse services in health centers, with a specific focus on treatment of opioid use disorders in underserved populations. [READ MORE]

 

^ Return to Top


Updates in HIV for All Providers: Key Studies from CROI 2016 (3-17-2016)

Posted March 17, 2016

Dr. Natasha Chida summarizes some of the key studies presented at CROI 2016. The annual conference reviews critical basic, translational, and clinical HIV research from around the world. [READ MORE]

 

^ Return to Top


NYS Clinical Education: New Learning Module & STD Conference (3-15-2016)

Posted March 15, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

 

^ Return to Top


CDC Releases Guideline for Prescribing Opioids for Chronic Pain (3-15-2016)

Posted March 15, 2016

As part of the urgent response to the epidemic of overdose deaths, CDC issued new recommendations for prescribing opioid medications for chronic pain, excluding cancer, palliative, and end-of-life care. The CDC Guideline for Prescribing Opioids for Chronic Pain, United States, 2016 (PDF) will help primary care providers ensure the safest and most effective treatment for their patients.

For more information, please click here.

 

^ Return to Top


NIAID to Fund Further Study of Dapivirine Vaginal Ring for HIV Prevention in Women (3-15-2016)

Posted March 15, 2016

NIAID to Fund Further Study of Dapivirine Vaginal Ring for HIV Prevention Investment in HOPE Trial Augments Development of Next-Generation Prevention Tools

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that it would move forward with an open-label extension study of an HIV prevention tool for women: a silicone ring that continuously releases the experimental antiretroviral drug dapivirine in the vagina. [READ MORE]

 

^ Return to Top


Liver Cancer Death Rate Increasing Faster Than All Other Cancers (3-14-2016)

Posted March 14, 2016

On March 9th, the American Cancer Society, Centers for Disease Control and Prevention (CDC), National Cancer Institute, and the North American Association of Central Cancer Registries released their Annual Report to the Nation on the Status of Cancer, revealing that the rate of new cases of liver cancer is rapidly increasing and the death rate from liver cancer is increasing faster than from all other cancers. [READ MORE]

 

^ Return to Top


VA Expands Hepatitis C Drug Treatment (3-11-2016)

Posted March 11, 2016

The Department of Veterans Affairs (VA) today announced that it is now able to fund care for all Veterans with hepatitis C for Fiscal Year 2016 regardless of the stage of the patient’s liver disease. The move follows increased funding from Congress along with reduced drug prices. [READ MORE]

 

^ Return to Top


CROI 2016 Resources (3-11-2016)

Posted March 11, 2016

CDC, NCHHSTP resources presented at CROI 2016 are posted on the CDC website. The collection includes press releases, new data, high quality graphics and new studies of interest. Click on the link below to access the materials.

Resources

 

^ Return to Top


Rapid HIV Testing Online Course (3-11-2016)

Posted March 11, 2016

This course provides an opportunity for HIV prevention providers working in non-clinical settings to gain knowledge and skills on administering rapid HIV testing. Rapid HIV Testing will allow providers greater reach into places where HIV testing has not been available. The on-line course has four modules:

  • Overview and Introduction to Rapid HIV Testing
  • Safe Work Practices and Specimen Collection for Rapid HIV Testing
  • Quality Assurance and Quality Control in a Rapid HIV Testing Environment
  • HIV Prevention Counseling and Providing Rapid HIV Test Results

The modules will take approximately 5 hours to complete, if completed in one setting. All materials are based on CDC guidelines, protocols and established best practices related to rapid HIV testing, as seen in clinical and non-clinical settings. The course is available until December 31, 2020.

Register

 

^ Return to Top


A Framework for Educating Health Professionals to Address the Social Determinants of Health (3-11-2016)

Posted March 11, 2016

The National Academies of Sciences, Engineering, and Medicine convened a workshop to develop a high-level framework to educate health professionals about the social determinants of health, and increase awareness about the potential root causes of ill health, and importance of addressing them in/with communities. This resource provides a model for the framework’s use; it is intended to help stakeholder groups envision ways organizations, educators, and communities can come together to address health inequalities.

Purchase or download this resource

 

^ Return to Top


NQC Special Announcement: Next TCB Session: May 23-25, Atlanta, GA (3-10-2016)

Posted March 10, 2016

The National Quality Center (NQC), administered by the New York State Department of Health, is proud to announce its next Training on Coaching Basics (TCB) session in Atlanta, GA. This program is designed to close the educational gap of quality managers and enlarge the pool of quality improvement (QI) coaches nationwide to meet the needs of the Ryan White HIV/AIDS Program requirements for clinical quality management. The rigorous learning experience includes pre-work activities (approximately 5-6 hours) and a 3-day face-to-face session and up to 12 to 15 hours of post-work activities. The TCB Program provides information on basic concepts in quality management and coaching, effective coaching practices, and strategies for assessing improvement. To gain an in-depth understanding of the TCB, please use the link below and download the TCB Concept Paper.

The upcoming TCB session will be occur from May 23 through May 25, 2016. We invite you to apply. NQC offers this program with no registration fee. To start the application process, open the Applying to the TCB in Atlanta document and follow the link to the online application or access the application through the NQC website by going to NationalQualityCenter.org\TCB.

If you have any questions about the TCB Program, please contact Kevin Garrett, LMSW at kevin.garrett@health.ny.gov. If you would like to learn more about the NQC, please visit our website at NationalQualityCenter.org\TCB.

 

^ Return to Top


AETC Program Quarterly Newsletter - Spring 2016 (3-8-2016)

Posted March 8, 2016

The AETC Program Quarterly Newsletter – Spring Edition is now available. It can be viewed here, or accessed via the AETC National Coordinating Resource Center website here.

Remember, you may submit items for inclusion in an upcoming Newsletter at any time. The next Newsletter will post in June 2016, so please visit the Announcement Item Submissions page on our website for more information about submission guidelines and deadlines.

 

^ Return to Top


FDA Safety Alert (Recall): Fluconazole Injection, USP, 200mg per 100ml: Elevated Impurity (3-7-2016)

Posted March 7, 2016

Sagent has initiated a voluntary recall of one lot of Fluconazole Injection, USP, 200mg per 100mL to the user level due to the discovery of an out of specification impurity result detected during routine quality testing of stability samples at the 18-month interval. This impurity has been identified as Metronidazole. An elevated impurity has the potential to decrease effectiveness of the product in patients. Patients on the product and on concomitant medication of Metronidazole may receive an increased dose of Metronidazole.

To view the entire FDA Safety Alert, please visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm489316.htm

 

^ Return to Top


FDA Bulletin: STRIBILD Label Updated (3-7-2016)

Posted March 7, 2016

Recently the STRIBILD® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablet label was updated to include drug-drug interaction information with quetiapine and ledipasvir/sofosbuvir and to update section 12.2 with information on the effects on serum creatinine.

The changes to the label are summarized here.

 

^ Return to Top


FDA Bulletin: Olysio Label Revised (3-7-2016)

Posted March 7, 2016

The OLYSIO (simeprevir) label was updated to include pharmacokinetic, safety and efficacy data in treatment-naïve adult patients of East Asian ancestry with chronic hepatitis C virus genotype 1 infection.

To read the complete FDA bulletin, please visit http://content.govdelivery.com/accounts/USFDA/bulletins/139af19

 

^ Return to Top


XOXO: Put Your #BestDefense Into Play (3-7-2016)

Posted March 7, 2016

Ever heard the phrase “The Best Defense Is a Good Offense”? Sure, it’s generally a sports phrase, but why can’t it apply to sex, too? This National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) — celebrated March 10 — is all about prevention. When it comes to sex, we want all women and girls to “gear up.” [READ MORE]

 

^ Return to Top


Governor Cuomo Announces Narcan Now Available at Independent Pharmacies (3-4-2016)

Posted March 4, 2016

Governor Andrew M. Cuomo today announced independent pharmacies across the state will now be able to provide naloxone to their customers without a prescription. Naloxone – also known as Narcan® – is a medication that reverses opioid overdose. Improved accessibility to the medication is one of the priorities at the center of the Governor’s fight to end opioid abuse in New York State.

View the entire press release by visiting https://www.governor.ny.gov/news/governor-cuomo-announces-narcan-now-available-independent-pharmacies

 

^ Return to Top


FDA Bulletin: COMPLERA label updated (3-4-2016)

Posted March 4, 2016

The COMPLERA (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) label was recently updated to expand the patient population for use to include pediatric patients from 12 to less than 18 years of age. Other revisions were made for consistency with the Edurant (rilpivirine) label and the major changes are summarized here.

 

^ Return to Top


Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S. (3-4-2016)

Posted March 4, 2016

In 2014, the World Health Organization’s (WHO) World Health Assembly unanimously adopted resolution WHA67.6, which urged Member States and the WHO Director-General to enhance efforts in viral hepatitis surveillance, prevention, treatment access, and disease control. This resolution tasked the WHO with assessing the feasibility of elimination targets for hepatitis B (HBV) and hepatitis C (HCV) viruses. As a result, the WHO is developing a Global Health Sector Strategy on Viral Hepatitis, 2016-2021, due to be released later this year, to guide global action and supplement existing activities in addressing viral hepatitis. [READ MORE]

 

^ Return to Top


Email Announcement Archives

The HIV Clinical Guidelines Program provides subscribers with email announcements of when new guidelines are posted and existing guidelines are updated.

hivguidelines email announcement archives

hivguidelines Trends, Topics & Updates monthly mailer archives

Subscribe to hivguidelines email announcements

 

^ Return to Top


Hot Topics Archive

Please visit the Hot Topics Archive page.

^ Return to Top